BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ross LF, Rothstein MA, Clayton EW. Premature guidance about whole-genome sequencing. Per Med 2013;10:523-6. [PMID: 24348686 DOI: 10.2217/pme.13.51] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Lázaro-Muñoz G, Conley JM, Davis AM, Prince AE, Cadigan RJ. Which Results to Return: Subjective Judgments in Selecting Medically Actionable Genes. Genet Test Mol Biomarkers 2017;21:184-94. [PMID: 28146641 DOI: 10.1089/gtmb.2016.0397] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
2 Yu JH, Harrell TM, Jamal SM, Tabor HK, Bamshad MJ. Attitudes of genetics professionals toward the return of incidental results from exome and whole-genome sequencing. Am J Hum Genet 2014;95:77-84. [PMID: 24975944 DOI: 10.1016/j.ajhg.2014.06.004] [Cited by in Crossref: 89] [Cited by in F6Publishing: 81] [Article Influence: 11.1] [Reference Citation Analysis]
3 Berg JS, Foreman AK, O'Daniel JM, Booker JK, Boshe L, Carey T, Crooks KR, Jensen BC, Juengst ET, Lee K, Nelson DK, Powell BC, Powell CM, Roche MI, Skrzynia C, Strande NT, Weck KE, Wilhelmsen KC, Evans JP. A semiquantitative metric for evaluating clinical actionability of incidental or secondary findings from genome-scale sequencing. Genet Med 2016;18:467-75. [PMID: 26270767 DOI: 10.1038/gim.2015.104] [Cited by in Crossref: 47] [Cited by in F6Publishing: 49] [Article Influence: 6.7] [Reference Citation Analysis]
4 Berg JS, Powell CM. Potential Uses and Inherent Challenges of Using Genome-Scale Sequencing to Augment Current Newborn Screening. Cold Spring Harb Perspect Med 2015;5:a023150. [PMID: 26438605 DOI: 10.1101/cshperspect.a023150] [Cited by in Crossref: 15] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
5 Lemke AA, Harris-Wai JN. Stakeholder engagement in policy development: challenges and opportunities for human genomics. Genet Med 2015;17:949-57. [PMID: 25764215 DOI: 10.1038/gim.2015.8] [Cited by in Crossref: 36] [Cited by in F6Publishing: 25] [Article Influence: 5.1] [Reference Citation Analysis]
6 Brothers KB, Lynch JA, Aufox SA, Connolly JJ, Gelb BD, Holm IA, Sanderson SC, McCormick JB, Williams JL, Wolf WA, Antommaria AH, Clayton EW. Practical guidance on informed consent for pediatric participants in a biorepository. Mayo Clin Proc 2014;89:1471-80. [PMID: 25264176 DOI: 10.1016/j.mayocp.2014.07.006] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
7 Geller G, Dvoskin R, Thio CL, Duggal P, Lewis MH, Bailey TC, Sutherland A, Salmon DA, Kahn JP. Genomics and infectious disease: a call to identify the ethical, legal and social implications for public health and clinical practice. Genome Med 2014;6:106. [PMID: 25593592 DOI: 10.1186/s13073-014-0106-2] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
8 Yamamoto K, Hachiya T, Fukushima A, Nakaya N, Okayama A, Tanno K, Aizawa F, Tokutomi T, Hozawa A, Shimizu A. Population-based biobank participants' preferences for receiving genetic test results. J Hum Genet 2017;62:1037-48. [PMID: 28794501 DOI: 10.1038/jhg.2017.81] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]